The global urinary tract infection market is anticipated to grow at a CAGR of 4.8% during the forecast period (2021-2027). The key factor to drive the market growth is the increasing prevalence of diabetes and obesity due to the adoption of unhealthy lifestyles and increasing addiction to alcohol and obesity in many countries. For instance, according to International Diabetes Association in 2019, Diabetes affects approximately 463 million people aged 20 to 79, with the number expected to increase to 700 million by 2045. Diabetes cost the US economy at least $760 billion in 2019, accounting for 10% of total adult spending. Further, Adult obesity rates now exceed 35% in 12 states, 30% in 35 states, and 25% in 48 states, according to the most recent Behavioural Risk Factor Surveillance System (BRFSS) data. Mississippi has the highest adult obesity rate (40.8%), while Colorado and Washington, DC have the lowest (23.8%). Between the years 2018 and 2019,
Browse the full report description Global Urinary Tract Infection Market Size, Share & Trends Analysis Report By Test Type (Biochemical Urinary Tract Infection, Microscopic Urinary Tract Infection, Flow Cytometric Urinary Tract Infection) By Indication (Complicated Urinary Tract Infection, Uncomplicated Urinary Tract Infection, Neurogenic Bladder Infections), End-User (Hospitals & Clinics, and Home Healthcare) Forecast Period 2021-2027 at https://www.omrglobal.com/industry-reports/urinary-tract-infection-treatment-market
Rising acquisitions, product approval, collaborations among the major players if the market also propel the growth of the market. For instance, in July 2019, Recarbrioan antibacterial drug product has been approved by the US Food and Drug Administration (FDA) to treat adults with complicated urinary tract infections and complicated intra-abdominal infections. With this approval The FDA is committed to encouraging the production of new antibacterial drugs that are both safe and reliable, giving patients more choices in the battle against severe infections.
Market Coverage
o By Test Type
o By Indication
o By End-User
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Urinary Tract Infection Market Report Segment
BY Test Type
BY Indication
By End-User
Global Urinary Tract Infection Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/urinary-tract-infection-treatment-market